Associated Papers
Concomitant MEK and Cyclin Gene Alterations: Implications for Response to Targeted Therapeutics.
Kato S et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2021
Targeting G1/S phase cell-cycle genomic alterations and accompanying co-alterations with individualized CDK4/6 inhibitor-based regimens.
Kato S et al.
Jci Insight, 2021
33427211 (PubMed )
Supplement: jciinsight-6-142547-s159.pdf
Male child with somatic mosaic Osteopathia Striata with Cranial Sclerosis caused by a novel pathogenic AMER1 frameshift mutation.
Hague J et al.
American Journal of Medical Genetics. Part A, 2017
Osteopathia striata with cranial sclerosis and developmental delay in a male with a mosaic deletion in chromosome region Xq11.2.
Chénier S et al.
American Journal of Medical Genetics. Part A, 2012
Two novel WTX mutations underscore the unpredictability of male survival in osteopathia striata with cranial sclerosis.
Perdu B et al.
Clinical Genetics, 2011
Mosaicism in osteopathia striata with cranial sclerosis.
Joseph DJ et al.
The Journal of Clinical Endocrinology and Metabolism, 2010
Select a paper to view details